logo

Valeant Pharmaceuticals International (VRX.TO)



Trade VRX.TO now with
  Date
  Headline
4/9/2018 7:03:58 AM Ortho Dermatologics Announces Publication Of Pivotal Efficacy And Safety Data For Psoriasis Treatment DUOBRII In JAAD
4/6/2018 8:34:00 AM EyeGate Completes Enrollment And Gets Milestone Payment For Confirmatory Phase 3 Clinical Study Of EGP-437
3/26/2018 7:02:33 AM Valeant Report Early Tender Results And Early Settlement Date For Cash Tender Offers For Senior Notes
3/12/2018 7:32:16 AM Valeant Launches Private Offering Of Senior Notes
2/28/2018 7:03:57 AM Valeant Pharma Q4 EPS $1.45 Vs Loss $1.47 Last Year
2/28/2018 7:02:14 AM Valeant Pharma Q4 Total Revenues $2.163 Bln Vs $2.403 Bln Last Year
2/14/2018 7:04:38 AM Ortho Dermatologics Announces FDA Filing Acceptance For JEMDEL Plaque Psoriasis Treatment
2/9/2018 9:10:54 AM Salix Provides Update On FDA Submission For PLENVU
1/12/2018 7:01:48 AM Ortho Dermatologics Announces FDA Filing Acceptance For IDP-121 Acne Treatment In Lotion Form